Serum bilirubin affects graft outcomes through UDP-glucuronosyltransferase sequence variation in kidney transplantation

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Lee, Jung Pyo ^a   Kim, Do Hyoung ^b   Yang, Seung Hee ^a   Hwang, Jin Ho ^b   An, Jung Nam ^a   Min, Sang Il ^a   Ha, Jongwon ^a   Oh, Yun Kyu ^a   Kim, Yon Su ^a   Lim, Chun Soo ^a  

^a Seoul National University   (South Korea)

^b Chung Ang University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; GLUCURONOSYLTRANSFERASE; GLUCURONOSYLTRANSFERASE 1A1; HEME OXYGENASE 1; ANTIOXIDANT; UGT1A1 ENZYME;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; BILIRUBIN BLOOD LEVEL; FEMALE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; GRAFT FAILURE; GRAFT SURVIVAL; HOMOZYGOTE; HUMAN; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; SOUTH KOREA; ADVERSE EFFECTS; BLOOD; GENETIC ASSOCIATION; GENETICS; GRAFT REJECTION; METABOLISM; MIDDLE AGED; OXIDATIVE STRESS; PATHOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ANTIOXIDANTS; BILIRUBIN; FEMALE; GENETIC ASSOCIATION STUDIES; GENOTYPE; GLUCURONOSYLTRANSFERASE; GRAFT REJECTION; HEME OXYGENASE-1; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; OXIDATIVE STRESS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84898621283     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0093633     Document Type: Article

References (42)

1. Vostalova J, Galandakova A, Svobodova AR, Orolinova E, Kajabova M, et al. (2012) Time-course evaluation of oxidative stress-related biomarkers after renal transplantation. Ren Fail 34: 413-419.
2. Sun K, Kiss E, Bedke J, Stojanovic T, Li Y, et al. (2004) Role of xanthine oxidoreductase in experimental acute renal-allograft rejection. Transplantation 77: 1683-1692. (Pubitemid 38780534)
3. Cristol JP, Vela C, Maggi MF, Descomps B, Mourad G (1998) Oxidative stress and lipid abnormalities in renal transplant recipients with or without chronic rejection. Transplantation 65: 1322-1328. (Pubitemid 28283093)
4. Hasegawa T, Iwanaga K, Hultquist DE, Liao H, Visovatti SH, et al. (2009) Suppression of nitrosative and oxidative stress to reduce cardiac allograft vasculopathy. Am J Physiol Heart Circ Physiol 296: H1007-1016.
5. Otterbein LE, Soares MP, Yamashita K, Bach FH (2003) Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol 24: 449-455. (Pubitemid 36928103)
6. Abraham NG, Cao J, Sacerdoti D, Li X, Drummond G (2009) Heme oxygenase: the key to renal function regulation. Am J Physiol Renal Physiol 297: F1137-1152.
7. Ikushiro S, Emi Y, Iyanagi T (1997) Protein-protein interactions between UDPglucuronosyltransferase isozymes in rat hepatic microsomes. Biochemistry 36: 7154-7161. (Pubitemid 27258131)
8. Stocker R, Glazer AN, Ames BN (1987) Antioxidant activity of albumin-bound bilirubin. Proc Natl Acad Sci U S A 84: 5918-5922. (Pubitemid 17130420)
9. Llesuy SF, Tomaro ML (1994) Heme oxygenase and oxidative stress. Evidence of involvement of bilirubin as physiological protector against oxidative damage. Biochim Biophys Acta 1223: 9-14. (Pubitemid 24262847)
10. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN (1987) Bilirubin is an antioxidant of possible physiological importance. Science 235: 1043-1046. (Pubitemid 17049750)
11. Adin CA, Croker BP, Agarwal A (2005) Protective effects of exogenous bilirubin on ischemia-reperfusion injury in the isolated, perfused rat kidney. Am J Physiol Renal Physiol 288: F778-784. (Pubitemid 40381746)
12. Chin HJ, Cho HJ, Lee TW, Na KY, Oh KH, et al. (2009) The mildly elevated serum bilirubin level is negatively associated with the incidence of end stage renal disease in patients with IgA nephropathy. J Korean Med Sci 24 Suppl: S22-29.
13. Chin HJ, Cho HJ, Lee TW, Na KY, Yoon HJ, et al. (2009) The heme oxygenase-1 genotype is a risk factor to renal impairment of IgA nephropathy at diagnosis, which is a strong predictor of mortality. J Korean Med Sci 24 Suppl: S30-37.
14. Chen YH, Hung SC, Tarng DC (2011) Serum bilirubin links UGT1A1*28 polymorphism and predicts long-term cardiovascular events and mortality in chronic hemodialysis patients. Clin J Am Soc Nephrol 6: 567-574.
15. Kim SY, Jin DC, Bang BK (2003) Current status of dialytic therapy in Korea. Nephrology (Carlton) 8 Suppl: S2-9. (Pubitemid 38056407)
16. Bulmer AC, Blanchfield JT, Toth I, Fassett RG, Coombes JS (2008) Improved resistance to serum oxidation in Gilbert's syndrome: a mechanism for cardiovascular protection. Atherosclerosis 199: 390-396.
17. Lin JP, O'Donnell CJ, Schwaiger JP, Cupples LA, Lingenhel A, et al. (2006) Association between the UGT1A1*28 allele, bilirubin levels, and coronary heart disease in the Framingham Heart Study. Circulation 114: 1476-1481. (Pubitemid 44527002)
18. Vitek L, Jirsa M, Brodanova M, Kalab M, Marecek Z, et al. (2002) Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels. Atherosclerosis 160: 449-456. (Pubitemid 34159340)
19. Morena M, Delbosc S, Dupuy AM, Canaud B, Cristol JP (2005) Overproduction of reactive oxygen species in end-stage renal disease patients: a potential component of hemodialysis-associated inflammation. Hemodial Int 9: 37-46. (Pubitemid 40932774)
20. Antolini F, Valente F, Ricciardi D, Fagugli RM (2004) Normalization of oxidative stress parameters after kidney transplant is secondary to full recovery of renal function. Clin Nephrol 62: 131-137. (Pubitemid 39162765)
21. Joo DJ, Huh KH, Cho Y, Jeong JH, Kim JY, et al. (2010) Change in serum lipid peroxide as an oxidative stress marker and its effects on kidney function after successful kidney transplantation. Transplant Proc 42: 729-732.
22. Campise M, Bamonti F, Novembrino C, Ippolito S, Tarantino A, et al. (2003) Oxidative stress in kidney transplant patients. Transplantation 76: 1474-1478. (Pubitemid 37467697)
23. Zahmatkesh M, Kadkhodaee M, Mahdavi-Mazdeh M, Ghaznavi R, Hemati M, et al. (2010) Oxidative stress status in renal transplant recipients. Exp Clin Transplant 8: 38-44.
24. Nakagami T, Toyomura K, Kinoshita T, Morisawa S (1993) A beneficial role of bile pigments as an endogenous tissue protector: anti-complement effects of biliverdin and conjugated bilirubin. Biochim Biophys Acta 1158: 189-193. (Pubitemid 23291461)
25. Rocuts F, Zhang X, Yan J, Yue Y, Thomas M, et al. (2010) Bilirubin promotes de novo generation of T regulatory cells. Cell Transplant 19: 443-451.
26. Lee SS, Gao W, Mazzola S, Thomas MN, Csizmadia E, et al. (2007) Heme oxygenase-1, carbon monoxide, and bilirubin induce tolerance in recipients toward islet allografts by modulating T regulatory cells. FASEB J 21: 3450-3457. (Pubitemid 350075135)
27. Wang H, Lee SS, Dell'Agnello C, Tchipashvili V, d'Avila JC, et al. (2006) Bilirubin can induce tolerance to islet allografts. Endocrinology 147: 762-768. (Pubitemid 43112992)
28. Yamada N, Yamaya M, Okinaga S, Nakayama K, Sekizawa K, et al. (2000) Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema. Am J Hum Genet 66: 187-195. (Pubitemid 30481482)
29. Guenegou A, Leynaert B, Benessiano J, Pin I, Demoly P, et al. (2006) Association of lung function decline with the heme oxygenase-1 gene promoter microsatellite polymorphism in a general population sample. Results from the European Community Respiratory Health Survey (ECRHS), France. J Med Genet 43: e43.
30. Chen YH, Lin SJ, Lin MW, Tsai HL, Kuo SS, et al. (2002) Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2 diabetic patients. Hum Genet 111: 1-8.
31. Endler G, Exner M, Schillinger M, Marculescu R, Sunder-Plassmann R, et al. (2004) A microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with increased bilirubin and HDL levels but not with coronary artery disease. Thromb Haemost 91: 155-161. (Pubitemid 38111232)
32. Schillinger M, Exner M, Minar E, Mlekusch W, Mullner M, et al. (2004) Heme oxygenase-1 genotype and restenosis after balloon angioplasty: a novel vascular protective factor. J Am Coll Cardiol 43: 950-957. (Pubitemid 38352971)
33. Denschlag D, Marculescu R, Unfried G, Hefler LA, Exner M, et al. (2004) The size of a microsatellite polymorphism of the haem oxygenase 1 gene is associated with idiopathic recurrent miscarriage. Mol Hum Reprod 10: 211-214. (Pubitemid 38456024)
34. Kimpara T, Takeda A, Watanabe K, Itoyama Y, Ikawa S, et al. (1997) Microsatellite polymorphism in the human heme oxygenase-1 gene promoter and its application in association studies with Alzheimer and Parkinson disease. Hum Genet 100: 145-147. (Pubitemid 27309669)
35. Chen YH, Chau LY, Chen JW, Lin SJ (2008) Serum bilirubin and ferritin levels link heme oxygenase-1 gene promoter polymorphism and susceptibility to coronary artery disease in diabetic patients. Diabetes Care 31: 1615-1620.
36. Baan C, Peeters A, Lemos F, Uitterlinden A, Doxiadis I, et al. (2004) Fundamental role for HO-1 in the self-protection of renal allografts. Am J Transplant 4: 811-818. (Pubitemid 38637582)
37. Exner M, Bohmig GA, Schillinger M, Regele H, Watschinger B, et al. (2004) Donor heme oxygenase-1 genotype is associated with renal allograft function. Transplantation 77: 538-542. (Pubitemid 38282808)
38. Pileggi A, Molano RD, Berney T, Cattan P, Vizzardelli C, et al. (2001) Heme oxygenase-1 induction in islet cells results in protection from apoptosis and improved in vivo function after transplantation. Diabetes 50: 1983-1991. (Pubitemid 33643664)
39. Ribeiro MM, Klein D, Pileggi A, Molano RD, Fraker C, et al. (2003) Heme oxygenase-1 fused to a TAT peptide transduces and protects pancreatic betacells. Biochem Biophys Res Commun 305: 876-881. (Pubitemid 36597845)
40. Courtney AE, McNamee PT, Middleton D, Heggarty S, Patterson CC, et al. (2007) Association of functional heme oxygenase-1 gene promoter polymorphism with renal transplantation outcomes. Am J Transplant 7: 908-913. (Pubitemid 46481204)
41. Hribova P, Reinke P, Petrasek J, Brabcova I, Hubacek JA, et al. (2008) Heme oxygenase-1 polymorphisms and renal transplantation outcomes: balancing at the detection limit of allelic association studies. Am J Transplant 8: 1077-1078; author reply 1079. (Pubitemid 351537780)
42. Turpeinen H, Kyllonen LE, Parkkinen J, Laine J, Salmela KT, et al. (2007) Heme oxygenase 1 gene polymorphisms and outcome of renal transplantation. Int J Immunogenet 34: 253-257. (Pubitemid 47052423)